Michael Kosteljanetz

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.

Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.

Journal: Journal of neuro-oncology

Published: February 06, 2018

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.

Journal: Cancer investigation

Published: February 03, 2018

Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Journal: Journal of neuro-oncology

Published: February 19, 2017

Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.

Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.

Journal: European journal of human genetics : EJHG

Published: July 04, 2016

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients.

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients.

Journal: Molecular oncology

Published: March 05, 2016

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 02, 2016

Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.

Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.

Journal: Danish medical journal

Published: December 21, 2013

von Hippel-Lindau disease: deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening.

von Hippel-Lindau disease: deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening.

Journal: International journal of audiology

Published: September 06, 2013

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Journal: BMC cancer

Published: February 07, 2013

Danish Neuro-Oncology Registry

Danish Neuro-Oncology Registry

Journal: Ugeskrift for laeger

Published: October 20, 2012

Cancer packages: Does haste lead to more work?

Cancer packages: Does haste lead to more work?

Journal: Ugeskrift for laeger

Published: June 12, 2012

Brain perfusion CT compared with ¹⁵O-H₂O PET in patients with primary brain tumours.

Brain perfusion CT compared with ¹⁵O-H₂O PET in patients with primary brain tumours.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 10, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026